CHROMEDX CORP ORDINARY SHARES CANADA (OTCMKTS:CHXIF) Sellers Declined Their Shorts By 76%

April 16, 2018 - By Bridget Boland

It was showed a decrease on CHROMEDX CORP ORDINARY SHARES CANADA (OTCMKTS:CHXIF)’s shares shorted with 76%. It was issued in April by FINRA the 1,200 shares shorted on CHXIF. Previously was reported down change of 76% from 5,000 shares. CHROMEDX CORP ORDINARY SHARES CANADA (OTCMKTS:CHXIF) has 5,900 shares average volume. It’ll cost 0 days for CHXIF to restore its former position.

At traded at $0.26 lastly.Since April 16, 2017 it’s 0.00% down thus . CHXIF underperformed the S&P500 by 11.55%.

ChroMedX Corp., a medical technology company, engages in the research, development, and manufacture of in vitro diagnostics and point-of-care technologies in Canada.The firm is valued at $31.28 million. It offers novel medical devices for point of care testing, blood sample collection, and serum/plasma treatment and analysis.Last it reported negative earnings. The firm provides HemoPalm, a blood analysis system that integrates blood gases, electrolytes, CO-oximetry, and bilirubin in one hand-held analyzer; and Automatic Ultra-Filtration technology provides a sample preparation method, which is used for analysis of free hormones and therapeutic drugs through the automated system.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: